Izmir Chest Diseases and Surgery Education and Research Hospital, Intensive Care Unit
Izmir, Yenisehir, 35550, Turkey (Türkiye)
NCT Number: NCT01472302
Adaptive support ventilation (ASV) is a closed loop ventilation mode that can act both like PCV and PSV automatically. Some studies suggest that ASV can reduce the weaning time in ICU patients. The investigators hypothesized that using ASV from the beginning of intubation can reduce the total duration of MV and LOS in the ICU when compared to conventional modes such as PCV+PSV
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Phase 4
Izmir, Yenisehir, 35550, Turkey (Türkiye)
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ventilation protocol according to the patients ideal body weight
Ventilation protocol (6-8 ml/kg tidal volume) according to our ICU
Time frame: 1 year
Looking for future studies?
Notify MeIzmir Dr Suat Seren Chest Diseases and Surgery Education and Research Hospital
Other
Effect of a Closed Loop Ventilation Strategy on Reducing the Total Duration of Mechanical Ventilation of Intubated Intensive Care Unit Patients: A Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05261607
Epidemiology, Inflammation
Getafe, Madrid, Spain
View Trial DetailsNCT00810498
Respiration Disorders, Respiratory Failure
Winnipeg, Manitoba, Canada
View Trial DetailsNCT07821710
Mechanical Ventilation, Pulmonary Infection
Wuxi, Jiangsu, China
View Trial DetailsNCT03464695
COPD Exacerbation, COPD Exacerbation Acute
Hellerup, Denmark
View Trial Details